Drug Trial Radar · NCT04822181
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,205
Actual
Start
Apr 1, 2021
Primary completion
Apr 25, 2029
Study completion Apr 25, 2029
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Mar 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will either get semaglutide or a dummy medicine - which treatment participants get is decided by chance. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study will last for about 5 years. Participants will have up to 21 clinic visits and 9 phone calls with the clinical staff during the study. Some of the clinic visits may be spread over more than one day. Participants with other chronic liver diseases cannot take part in this study. Women cannot take part in the study if they are pregnant, breast-feeding or plan to become pregnant during the study period.
Conditions
- Non-alcoholic Steatohepatitis
Interventions
SemaglutideDrug
Semaglutide administrated subcutaneously (under the skin) once weekly there will be a period of dose escalation before reaching the target dose.
PlaceboDrug
Placebo administrated subcutaneously (under the skin) once weekly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: Resolution of steatohepatitis and no worsening of liver fibrosis (Yes/No)Time frame: From randomisation (week 0) to week 72
- Part 1: Improvement in liver fibrosis and no worsening of steatohepatitis (Yes/No)Time frame: From randomisation (week 0) to week 72
- Part 2: Cirrhosis-free survival (Yes/No)Time frame: From randomisation (week 0) to week 240
Locations
558 sites in 39 countries. Site status is shown where the registry gives one.
North AL Health Res, LLC
Huntsville, Alabama
The Institute for Liver Health
Chandler, Arizona
Inst-Liver Hlth dba AZ Liver H
Peoria, Arizona
Inst. Liver H II dba AZ Liver H
Tucson, Arizona
Del Sol Research Management, LLC
Tucson, Arizona
ARcare Center for Clinical Research
Jonesboro, Arkansas
ARcare Center for Clinical Research
Little Rock, Arkansas
Arkansas Diagnostic Center, PA
Little Rock, Arkansas
Gastroenterology & Liver Institute
Escondido, California
Shang Wu M.D. Inc.
Hacienda Heights, California
Scripps Whittier Diabetes Inst
La Jolla, California
UCSD NAFLD Research Center
La Jolla, California
OM Research LLC
Lancaster, California
Digestive Hlth Res of SoCa
Long Beach, California
OM Research LLC
Oxnard, California
Cedars-Sinai Medical Center
Pasadena, California
Pasedena Liver Center
Pasadena, California
Inland Empire Clin Trials LLC
Rialto, California
UC Davis Hlth -Midtwn Ambu Cen
Sacramento, California
University of California, San Francisco
San Francisco, California
San Jose Gastroenterology
San Jose, California
Peak Gastro Assoc-Col Springs
Colorado Springs, Colorado
Yale Ctr for Clin Invest
New Haven, Connecticut
Encore Medical Research of Boynton Beach LLC
Boynton Beach, Florida
Integrity Clinical Research, LLC
Doral, Florida
Covenant Metabolic Specialists, Ft. Myers
Fort Myers, Florida
University of Florida-CTRB
Gainesville, Florida
Miguel Rebollar PA
Hialeah, Florida
Direct Helpers Research Center
Hialeah, Florida
Florida Research Institute, LLC
Lakewood Rch, Florida
Sandhill Research, LLC
Maitland, Florida
Tandem Clinical Research - Maitland
Maitland, Florida
Optimus U, Corp
Miami, Florida
Univ of Miami/Schiff Ctr
Miami, Florida
Genoma Research Group, Inc
Miami, Florida
IMIC Inc
Miami, Florida
San Marcus Res Clin Miami Lakes
Miami Lakes, Florida
Ocala GI Research
Ocala, Florida
Sensible Healthcare LLC
Ocoee, Florida
Covenant Metabolic Specialists LLC
Sarasota, Florida
Showing 40 of 558 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.